首页> 外文期刊>Journal of neurosurgery. >Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.
【24h】

Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.

机译:对流增强6-羟基多巴胺进入大鼠纹状体引起的进行性广泛性多巴胺能变性:帕金森氏病的新型啮齿动物模型。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECT: A striatal dopamine lesion induces progressive nigral degeneration in rodents; however, intrastriatal injection of 6-hydroxydopamine (6-OHDA) causes only limited lesions due to spontaneous regeneration of the neurons that survive. To make an extensive lesion, the authors used a convection-enhanced delivery (CED) method for intrastriatal infusion of 6-OHDA and evaluated the animals for a model of Parkinson disease (PD). METHODS: Different doses of 6-OHDA were infused into the unilateral striatum in rats by using the CED method. The dopaminergic neuronal degeneration was evaluated based on morphological, biochemical, and behavioral measurements until 8 weeks postlesion. Due to the wide distribution of the drug, CED of 20 microg of 6-OHDA into the striatum was sufficient to obtain a progressive and extensive nigrostriatal lesion as defined by morphological (> 80% cell loss in the substantia nigra [SN]) and biochemical (> 95% decrease in striatal dopamine) criteria. The extent of the lesion manifested as a stable turning behavior with amphetamine (> 6 turns/minute) and apomorphine (> 4 turns/minute). It also appeared that at I week postlesion the apoptotic markers were maximal in neurons of the SN. CONCLUSIONS: A rat model of PD with a progressive and extensive dopamine lesion was successfully made by intrastriatal CED of 6-OHDA. In this model, the therapeutic value can be assessed using behavioral, biochemical, and histochemical measurements. The delay of nigral neuronal death with respect to the time of 6-OHDA administration may provide a therapeutic window for testing neuroprotective strategies.
机译:目的:纹状体多巴胺损伤可引起啮齿类动物进行性黑质变性。然而,纹状体内注射6-羟基多巴胺(6-OHDA)只能由于存活的神经元的自发再生而引起有限的病变。为了产生广泛的病变,作者使用对流增强输注(CED)方法进行纹状体内6-OHDA输注,并评估了动物的帕金森病(PD)模型。方法:采用CED法向大鼠单侧纹状体中注入不同剂量的6-OHDA。多巴胺能神经元变性的评估基于形态学,生化和行为学测量,直至病变后8周。由于药物的广泛分布,纹状体中20微克6-OHDA的CED足以获得进行性和广泛的黑质纹状体病变,这由形态学(黑质[SN]中细胞损失> 80%)和生化定义(纹状体多巴胺下降> 95%)标准。病变程度表现为苯丙胺(> 6转/分钟)和阿扑吗啡(> 4转/分钟)稳定的转弯行为。似乎在损伤后第一个星期,SN神经元中的凋亡标记物最大。结论:通过6-OHDA的纹状体内CED成功建立了具有进行性和广泛的多巴胺损伤的PD大鼠模型。在此模型中,可以使用行为,生化和组织化学测量来评估治疗价值。相对于6-OHDA给药时间,黑质神经元死亡的延迟可能为测试神经保护策略提供治疗窗口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号